These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35441310)

  • 21. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.
    Wu CC; Tseng CW; Tseng KC; Chen YC; Wu TW; Chang SY; Chang YJ; Chao YC; Hsu CS
    J Formos Med Assoc; 2021 May; 120(5):1249-1258. PubMed ID: 33288401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials.
    Wang Y; Luo Q; Li Y; Deng S; Wei S; Li X
    PLoS One; 2014; 9(1):e84484. PubMed ID: 24404166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
    Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis.
    Yang D; Zhuang B; Wang Y; Xie X; Xie X
    BMC Gastroenterol; 2020 Nov; 20(1):402. PubMed ID: 33246417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes.
    Min JH; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Sinn DH; Kim JM; Sohn I
    Clin Radiol; 2018 Jul; 73(7):676.e15-676.e24. PubMed ID: 29709236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.
    Kim GA; Shim JH; Kim MJ; Kim SY; Won HJ; Shin YM; Kim PN; Kim KH; Lee SG; Lee HC
    Br J Surg; 2016 Jan; 103(1):126-35. PubMed ID: 26572697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
    Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
    Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Kaida T; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2018 Feb; 38(2):1047-1052. PubMed ID: 29374739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small masses (≤3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation.
    Cha DI; Song KD; Kang TW; Lee MW; Rhim H
    Br J Radiol; 2020 Jan; 93(1105):20190719. PubMed ID: 31670571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical resection versus radiofrequency ablation for early recurrent hepatocellular carcinoma.
    Shi T; Xu C; Feng Y; Wei Y; Lv H; Zhu Q
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):844-851. PubMed ID: 35694799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term Outcomes of Hepatic Resection Combined With Intraoperative Ablation
    Ikuta S; Aihara T; Kasai M; Nakajima T; Yamanaka N
    Anticancer Res; 2024 May; 44(5):2133-2140. PubMed ID: 38677724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
    Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
    Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes.
    Cheung TT; Ng KK; Chok KS; Chan SC; Poon RT; Lo CM; Fan ST
    World J Gastroenterol; 2010 Jun; 16(24):3056-62. PubMed ID: 20572310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.